Oxford-based Eykona has raised £1.19 million to help commercialise its three-dimensional wound imaging system.

Oxford-based Eykona has raised £1.19 million to help commercialise its three-dimensional wound imaging system.

The Series A funding round was led by venture capitalist MTI through its UMIP Premier Fund. Other investors included H2O Venture Partners, Parkwalk EIS Technology Fund 1, Hygea VCT, the London Business Angels Roundtable EIS Fund and a number of other angel investors.

Technikos, a London-based venture capital fund specialising in medical technology, remains the largest shareholder in Eykona, which spun out from the University of Oxford in 1997.

Paul Murphy, Eykona’s CEO, comments, ‘We are at an exciting stage with Eykona, we have great clinical support, a strong health economic rationale and huge interest from the wound care community.

Adds Murphy, ‘Allowing clinicians to measure wounds, accurately and repeatably, will help improve outcomes, reduce costs and ensure that patients with serious wounds are treated optimally.’

Stephen Brindle, a partner at Technikos, claims Eykona’s technology could save the National Health Service up to £100 million a year.